Last updated on October 2018

Safety and Efficacy Study of Filgotinib GS-9876 and Tirabrutinib in Adults With Active Sjogren's Syndrome

Brief description of study

The primary objective of this study is to assess the efficacy of filgotinib, GS-9876, and tirabrutinib (formerly GS-4059) in adults with active Sjogren's Syndrome (SjS).

Clinical Study Identifier: NCT03100942

Contact Investigators or Research Sites near you

Start Over

Gilead Clinical Study Information Center

Centrum Medyczne Oporow
Wroclaw, Poland